Condition
Healthy Control Subjects
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 1 (1)
Trial Status
Completed3
Unknown2
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06735794Not ApplicableCompletedPrimary
Impact of Spaced iTBS on Plasticity in the Motor Cortex
NCT02298777Terminated
Metabolomic Analysis of Systemic Sclerosis
NCT06193824Not ApplicableUnknownPrimary
Optimisation of Eccentric Exercises
NCT02157389Not ApplicableCompleted
Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain
NCT02146300Not ApplicableUnknown
Effect of the Nasal Provocation on the Breathing Style
NCT01369017Phase 1CompletedPrimary
Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers
Showing all 6 trials